| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/29/2018 | Larimar Therapeutics, Inc. | ZFGN | Other (disposition) | Common Stock | 234.3k | $0.00 | $0 | | 06/29/2018 |
| 06/29/2018 | Larimar Therapeutics, Inc. | ZFGN | Other (disposition) | Common Stock | 1.1M | $0.00 | $0 | | 06/29/2018 |
| 03/24/2015 | Larimar Therapeutics, Inc. | ZFGN | Other (disposition) | Common Stock | 1000k | $0.00 | $0 | | 03/24/2015 |
| 06/24/2014 | Larimar Therapeutics, Inc. | ZFGN | Conversion | Common Stock | 759.2k | $0.00 | $0 | | 06/24/2014 |
| 06/24/2014 | Larimar Therapeutics, Inc. | ZFGN | Conversion | Common Stock | 2.8M | $0.00 | $0 | | 06/24/2014 |
| 06/24/2014 | Larimar Therapeutics, Inc. | ZFGN | Conversion | Common Stock | 1.3M | $0.00 | $0 | | 06/24/2014 |
| 06/24/2014 | Larimar Therapeutics, Inc. | ZFGN | Conversion | Common Stock | 746.9k | $0.00 | $0 | | 06/24/2014 |
| 06/24/2014 | Larimar Therapeutics, Inc. | ZFGN | Conversion | Series A Preferred Stock | 4.8M | $0.00 | $0 | | 06/24/2014 |
| 06/24/2014 | Larimar Therapeutics, Inc. | ZFGN | Conversion | Series B Preferred Stock | 17.7M | $0.00 | $0 | | 06/24/2014 |
| 06/24/2014 | Larimar Therapeutics, Inc. | ZFGN | Conversion | Series C Preferred Stock | 8.3M | $0.00 | $0 | | 06/24/2014 |
| 06/24/2014 | Larimar Therapeutics, Inc. | ZFGN | Conversion | Series D Preferred Stock | 4.7M | $0.00 | $0 | | 06/24/2014 |
| 02/11/2014 | Zyla Life Sciences | ZCOR | Conversion | Senior Convertible Debt | 0 | $6.00 | $0 | | 02/11/2014 |
| 02/11/2014 | Zyla Life Sciences | ZCOR | Exercise (in-the-money or at-the-money) | Warrants | 30k | $0.00 | $30 | | 02/11/2014 |
| 02/11/2014 | Zyla Life Sciences | ZCOR | Conversion | Series B Preferred Stock | 863.8k | $0.00 | $0 | | 02/11/2014 |
| 02/11/2014 | Zyla Life Sciences | ZCOR | Conversion | Series A-1 Preferred Stock | 833.1k | $0.00 | $0 | | 02/11/2014 |
| 02/11/2014 | Zyla Life Sciences | ZCOR | Purchase | Common Stock | 41.7k | $12.00 | $500k | | 02/11/2014 |
| 02/11/2014 | Zyla Life Sciences | ZCOR | Conversion | Common Stock | 85.6k | $6.00 | $513.7k | | 02/11/2014 |
| 02/11/2014 | Zyla Life Sciences | ZCOR | Conversion | Common Stock | 298.1k | $6.00 | $1.8M | | 02/11/2014 |
| 02/11/2014 | Zyla Life Sciences | ZCOR | Conversion | Common Stock | 863.8k | $0.00 | $0 | | 02/11/2014 |
| 02/11/2014 | Zyla Life Sciences | ZCOR | Conversion | Common Stock | 833.1k | $0.00 | $0 | | 02/11/2014 |
| 03/29/2010 | ARCA biopharma, Inc. | ABIO | Sale | Common Stock | 140k | $7.56 | $1.1M | | 03/29/2010 |